{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-24-006391","form_type":"8-K","ticker":"TOMZ","cik":"0000314227","company_name":"TOMI Environmental Solutions, Inc.","filed_at":"2024-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:21.519907+00:00","generated_at":"2026-06-01T23:46:27.082625+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"TOMI Q1 revenue $1.1M, net loss $0.07/share; backlog $900K and DHS contract for $2M noted","bullets":["Net revenue $1,114K, down 30% YoY from $1,582K; gross margin improved to 60.2% from 59.5%.","Net loss $1,310K ($0.07 per share) vs $1,187K ($0.06) in Q1 2023.","Sales backlog of $900K expected to convert in Q2 and Q3 2024.","DHS allocated ~$2M for 16 SteraMist Environment Systems at Plum Island Animal Disease Center.","iHP service revenue grew 21% YoY to $371K; new CES contract worth $600K signed."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-24-006391","json":"https://secwatch.observer/filing/0001654954-24-006391.json","markdown":"https://secwatch.observer/filing/0001654954-24-006391.md","text":"https://secwatch.observer/filing/0001654954-24-006391.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/314227/000165495424006391/0001654954-24-006391-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/314227/000165495424006391/tomz_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T23:46:27.082625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"29a23986237d62433335d7d6c86516fd608a0389","claim":"TOMI Environmental Solutions, Inc. reported first quarter ended March 31, 2024 results: revenue $1,114,000, net income ($1,310,000), EPS ($0.07) per basic and diluted share.","evidence_excerpt":"results and value for our shareholders,” Dr. Shane concluded. 1 Financial Results for the three months ended March 31, 2024, compared to March 31, 2023 · Total net revenue was $1,114,000 compared to $1,582,000. · Gross margin was 60.2% compared to 59.5%. · Operating loss was ($1,226,000), compared to ($1,188,000). · Net loss was ($1,310,000) or ($0.07) per basic","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/314227/000165495424006391/0001654954-24-006391-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$1,114,000"},{"label":"Net income","value":"($1,310,000)"},{"label":"EPS","value":"($0.07) per basic and diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}